BioCryst Net Debt To E B I T D A from 2010 to 2025

BCRX Stock  USD 8.31  0.23  2.69%   
BioCryst Pharmaceuticals Net Debt To EBITDA yearly trend continues to be fairly stable with very little volatility. Net Debt To EBITDA is likely to outpace its year average in 2025. Net Debt To EBITDA is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). View All Fundamentals
 
Net Debt To EBITDA  
First Reported
2010-12-31
Previous Quarter
(7.17)
Current Value
(6.82)
Quarterly Volatility
2.75485774
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioCryst Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioCryst Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1 M, Interest Expense of 103.4 M or Selling General Administrative of 279.4 M, as well as many indicators such as Price To Sales Ratio of 3.28, Dividend Yield of 0.0 or Days Sales Outstanding of 68.52. BioCryst financial statements analysis is a perfect complement when working with BioCryst Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of BioCryst Pharmaceuticals Correlation against competitors.
For more information on how to buy BioCryst Stock please use our How to Invest in BioCryst Pharmaceuticals guide.

Latest BioCryst Pharmaceuticals' Net Debt To E B I T D A Growth Pattern

Below is the plot of the Net Debt To E B I T D A of BioCryst Pharmaceuticals over the last few years. It is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). BioCryst Pharmaceuticals' Net Debt To EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioCryst Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Net Debt To E B I T D A10 Years Trend
Slightly volatile
   Net Debt To E B I T D A   
       Timeline  

BioCryst Net Debt To E B I T D A Regression Statistics

Arithmetic Mean(1.51)
Geometric Mean0.67
Coefficient Of Variation(182.80)
Mean Deviation2.17
Median(0.27)
Standard Deviation2.75
Sample Variance7.59
Range8.0544
R-Value(0.74)
Mean Square Error3.73
R-Squared0.54
Significance0
Slope(0.43)
Total Sum of Squares113.84

BioCryst Net Debt To E B I T D A History

2025 -6.82
2024 -7.17
2023 -6.34
2022 -3.04
2021 -0.73
2020 0.88
2019 0.31

About BioCryst Pharmaceuticals Financial Statements

BioCryst Pharmaceuticals investors use historical fundamental indicators, such as BioCryst Pharmaceuticals' Net Debt To E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioCryst Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Debt To EBITDA(7.17)(6.82)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioCryst Stock Analysis

When running BioCryst Pharmaceuticals' price analysis, check to measure BioCryst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCryst Pharmaceuticals is operating at the current time. Most of BioCryst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of BioCryst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCryst Pharmaceuticals' price. Additionally, you may evaluate how the addition of BioCryst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.